Anti-CTLA-4 antibodies in cancer immunotherapy: selective depletion of intratumoral regulatory T cells or checkpoint blockade?

Overview of attention for article published in Cell & Bioscience, April 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 1 news outlet
twitter: 2 X users

patent: 1 patent

Citations

dimensions_citation: 89 Dimensions

Readers on

mendeley: 139 Mendeley

Summary News X Patents Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 382 followers.

Anti-CTLA-4 antibodies in cancer immunotherapy: selective depletion of intratumoral regulatory T cells or checkpoint blockade? https://t.co/u80u8nimdU TL,DR: #antictla4 #checkpointblockade could work in part by depletion of tregs rather than “reinvigorat

22 Sep 2018

Reply Repost Favourite

Anti-CTLA-4 antibodies in cancer immunotherapy: selective depletion of intratumoral regulatory T cells or checkpoint blockade? https://t.co/ijV30eq7X0 https://t.co/nYtkLSMSgU

18 Apr 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.